MARKET

LGND

LGND

Ligand Pharma
NASDAQ
72.75
+1.48
+2.08%
Opening 13:54 03/28 EDT
OPEN
71.29
PREV CLOSE
71.27
HIGH
72.85
LOW
71.29
VOLUME
43.75K
TURNOVER
0
52 WEEK HIGH
94.57
52 WEEK LOW
49.24
MARKET CAP
1.29B
P/E (TTM)
24.77
1D
5D
1M
3M
1Y
5Y
Ligand Pharmaceuticals gains amid bullish investor pitch
Ligand Pharmaceuticals rose 4.2% amid bullish investor pitch. The pharmaceutical firm was pitched by Sandy Villere on CNBC. Ligand has a market cap of $1.2 billion and Viking Therapeutics is valued at $8.8 billion.
Seeking Alpha · 1d ago
Ligand Pharmaceuticals (LGND) Falls More Steeply Than Broader Market: What Investors Need to Know
NASDAQ · 2d ago
Weekly Report: what happened at LGND last week (0318-0322)?
Weekly Report · 3d ago
Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock
NASDAQ · 03/21 13:00
Ligand Pharmaceuticals (LGND) Exceeds Market Returns: Some Facts to Consider
NASDAQ · 03/20 22:00
Ligand (LGND) Is Considered a Good Investment by Brokers: Is That True?
NASDAQ · 03/19 13:30
Weekly Report: what happened at LGND last week (0311-0315)?
Weekly Report · 03/18 12:11
Ligand Pharmaceuticals (LGND) Declines More Than Market: Some Information for Investors
NASDAQ · 03/14 22:00
More
About LGND
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol platform technology is a chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. This technology has enabled several United States Food and Drug Administration (FDA)-approved products, including Gilead's Veklury, Amgen's Kyprolis, Baxter International's Nexterone, Melinta Therapeutics' Baxdela and Sage Therapeutics' Zulresso. Its technologies also include HepDirect, LTP and BEPro Technology Platform, SUREtechnology Platform (owned by Selexis), and Pelican Expression Technology. It has established multiple alliances, licenses and other business relationships with various pharmaceutical companies including Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences and Baxter International.

Webull offers Ligand Pharmaceuticals Inc stock information, including NASDAQ: LGND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LGND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LGND stock methods without spending real money on the virtual paper trading platform.